Cargando…

Novel avian paramyxovirus-based vaccine vectors expressing the Ebola virus glycoprotein elicit mucosal and humoral immune responses in guinea pigs

Paramyxovirus vaccine vectors based on human parainfluenza virus type 3 (HPIV-3) and Newcastle disease virus (NDV) have been previously evaluated against Ebola virus (EBOV) challenge. Although both the viral vectored vaccines efficiently induce protective immunity, some concerns remain to be solved....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Asuka, Kim, Shin-Hee, Manoharan, Vinoth K., Varghese, Berin P., Paldurai, Anandan, Samal, Siba K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445115/ https://www.ncbi.nlm.nih.gov/pubmed/30940854 http://dx.doi.org/10.1038/s41598-019-42004-4

Ejemplares similares

A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
por: Shirvani, Edris, et al.
Publicado: (2020)

Author Correction: A recombinant avian paramyxovirus serotype 3 expressing the hemagglutinin protein protects chickens against H5N1 highly pathogenic avian influenza virus challenge
por: Shirvani, Edris, et al.
Publicado: (2020)

Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2018)

Author Correction: A Recombinant Newcastle Disease Virus (NDV) Expressing S Protein of Infectious Bronchitis Virus (IBV) Protects Chickens against IBV and NDV
por: Shirvani, Edris, et al.
Publicado: (2020)

Contributions of HA1 and HA2 Subunits of Highly Pathogenic Avian Influenza Virus in Induction of Neutralizing Antibodies and Protection in Chickens
por: Shirvani, Edris, et al.
Publicado: (2020)

Complete Genome Sequence of Avian Paramyxovirus (APMV) Serotype 5 Completes the Analysis of Nine APMV Serotypes and Reveals the Longest APMV Genome
por: Samuel, Arthur S., et al.
Publicado: (2010)

Complete Genome Sequence of an Avian Paramyxovirus Type 4 from North America Reveals a Shorter Genome and New Genotype
por: Parthiban, Manoharan, et al.
Publicado: (2013)

Evaluation of the Replication, Pathogenicity, and Immunogenicity of Avian Paramyxovirus (APMV) Serotypes 2, 3, 4, 5, 7, and 9 in Rhesus Macaques
por: Khattar, Sunil K., et al.
Publicado: (2013)

Avian Paramyxovirus Type-3 as a Vaccine Vector: Identification of a Genome Location for High Level Expression of a Foreign Gene
por: Yoshida, Asuka, et al.
Publicado: (2017)

Experimental Infection of Mice with Avian Paramyxovirus Serotypes 1 to 9
por: Khattar, Sunil K., et al.
Publicado: (2011)

Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9
por: Samuel, Arthur S, et al.
Publicado: (2011)

Experimental avian paramyxovirus serotype-3 infection in chickens and turkeys
por: Kumar, Sachin, et al.
Publicado: (2010)

Comparative Protective Efficacies of Novel Avian Paramyxovirus-Vectored Vaccines against Virulent Infectious Bronchitis Virus in Chickens
por: Shirvani, Edris, et al.
Publicado: (2020)

Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens
por: Kim, Shin-Hee, et al.
Publicado: (2014)

Evaluation of fusion protein cleavage site sequences of Newcastle disease virus in genotype matched vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2017)

Recovery of Recombinant Avian Paramyxovirus Type-3 Strain Wisconsin by Reverse Genetics and Its Evaluation as a Vaccine Vector for Chickens
por: Elbehairy, Mohamed A., et al.
Publicado: (2021)

Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006
por: Mohamed, Mahmoud HA, et al.
Publicado: (2011)

Molecular characterization and complete genome sequence of avian paramyxovirus type 4 prototype strain duck/Hong Kong/D3/75
por: Nayak, Baibaswata, et al.
Publicado: (2008)

Development of a recombinant Newcastle disease virus-vectored vaccine for infectious bronchitis virus variant strains circulating in Egypt
por: Abozeid, Hassanein H., et al.
Publicado: (2019)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

Paramyxoviruses of Animals
por: Samal, S.K.
Publicado: (2008)

Mutations in the Fusion Protein Cleavage Site of Avian Paramyxovirus Serotype 4 Confer Increased Replication and Syncytium Formation In Vitro but Not Increased Replication and Pathogenicity in Chickens and Ducks
por: Kim, Shin-Hee, et al.
Publicado: (2013)

Complete Genome Sequence of a Highly Virulent Newcastle Disease Virus Currently Circulating in Mexico
por: Xiao, Sa, et al.
Publicado: (2013)

Newcastle Disease Virus Fusion Protein Is the Major Contributor to Protective Immunity of Genotype-Matched Vaccine
por: Kim, Shin-Hee, et al.
Publicado: (2013)

Effects of Naturally Occurring Six- and Twelve-Nucleotide Inserts on Newcastle Disease Virus Replication and Pathogenesis
por: Paldurai, Anandan, et al.
Publicado: (2014)

Paramyxovirus Glycoproteins and the Membrane Fusion Process
por: Aguilar, Hector C., et al.
Publicado: (2016)

A set of RT-PCR assays for detection of all known avian paramyxoviruses and application in surveillance of avian paramyxoviruses in China
por: Jin, Ji-Hui, et al.
Publicado: (2021)

A paramyxovirus-like model for Ebola virus bipartite promoters
por: Gutsche, Irina, et al.
Publicado: (2020)

Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019)

Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain
por: Xiao, Sa, et al.
Publicado: (2012)

Correction: Generation by Reverse Genetics of an Effective, Stable, Live-Attenuated Newcastle Disease Virus Vaccine Based on a Currently Circulating, Highly Virulent Indonesian Strain
por: Xiao, Sa, et al.
Publicado: (2022)

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
por: DiNapoli, Joshua M., et al.
Publicado: (2010)

Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection
Publicado: (1980)

The Effect of Vaccination on the Evolution and Population Dynamics of Avian Paramyxovirus-1
por: Chong, Yee Ling, et al.
Publicado: (2010)

Phylogenetic analysis of avian paramyxovirus serotype-1 in pigeons in Japan
por: MASE, Masaji, et al.
Publicado: (2015)

Circulation of avian paramyxoviruses in wild birds of Kazakhstan in 2002–2013
por: Karamendin, Kobey, et al.
Publicado: (2016)

Does Avian Coronavirus Co-Circulate with Avian Paramyxovirus and Avian Influenza Virus in Wild Ducks in Siberia?
por: Sharshov, Kirill, et al.
Publicado: (2023)

Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors
por: Meyer, Michelle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4rn65tdqdcfijcd3p65qit99c3